Sun Pharma Q2 Profit Drops 36% Due to Litigation Costs
Sun Pharma's net profit for Q2FY27 fell 36% to Rs 1,989 crore, impacted by exceptional litigation and acquisition-related expenses. Despite this, revenue increased by 11.8%, driven by strong sales in domestic and emerging markets. However, US formulations sales weakened during the quarter, affecting overall earnings.
ET Markets·




